11 April 2024

IAMA Therapeutics Appoints Federico Bolognani as Chief Medical Officer

GENOA, Italy, April 11, 2024 — IAMA Therapeutics today announced the appointment of Federico Bolognani, MD, PhD, as Chief Medical Officer (CMO). Bringing extensive expertise in […]
19 February 2024

IAMA Therapeutics Successfully Dosed the First Two Cohorts in First-in-Human Clinical Trial

GENOA, Italy, February 19, 2024 — IAMA Therapeutics has successfully dosed the first two cohorts of subjects and has started dosing the third one in the […]